Improved treatment
CA 2426049 A1 · Owner: Ekstrand, Helene · Inventors: Zimmerman, Thom J.; Jonsson, Per; Challoner, Teresa
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to using two or more agents in combination with capacity of reducing the intraocular pressure in a therapy with an improved efficacy to treat advanced glaucoma in such patients who suffer from detectable vision related impairments, when said agents are administered simultaneously. The combined use will also find advantage in treatment of individuals in need of a high IOP-reduction such as those being exposed to , risk factors rendering them susceptible to visual impairments.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 12, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 12, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 12, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.